Atoltivimab/Maftivimab/Odesivimab | m-entrepreneurship.com

Product Name :
Atoltivimab/Maftivimab/Odesivimab

Search keywords :
EB3

drugId :
null

Target Vo:
Envelope glycoprotein

Target Vo Short Name :
GP

Moa_Name:
Envelope glycoprotein inhibitors

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Regeneron Pharmaceuticals Inc

Active Indication_Name:
Hemorrhagic Fever, Ebola

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TSG101 Antibody
Phospho-eIF2A (Ser51) Antibody
SRT Tag Antibody (YA884): SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.

Author: Betaine hydrochloride

Related Posts